Target Name: ZNF19
NCBI ID: G7567
Review Report on ZNF19 Target / Biomarker Content of Review Report on ZNF19 Target / Biomarker
ZNF19
Other Name(s): zinc finger protein 19 | Zinc finger protein 19 (KOX 12) | zinc finger protein KOX12 | zinc finger protein 19 (KOX 12) | Zinc finger protein KOX12 | ZNF19_HUMAN | Zinc finger protein 19 | KOX12

ZNF19: A Potential Drug Target and Biomarker

Introduction

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZNF19, a member of the ZNF family, is a protein that has been identified as a potential drug target and biomarker. In this article, we will explore the biology of ZNF19, its potential drug targets, and its potential as a biomarker for various diseases.

biological background

Zinc finger proteins (ZFPs) are a class of non-coding RNAs that play important roles in various cellular processes. ZNF19, a protein belonging to the ZNF family, has been identified as a potential drug target and biomarker. In this article, we explore the biology of ZNF19, its potential drug targets, and its potential as a biomarker for various diseases.

Functions of ZNF19

ZNF19 is a transcription factor expressed in multiple cell types. It plays an important role in cell proliferation, differentiation and tumorigenesis. ZNF19 interacts with a variety of proteins, including transcription factors, co-regulated proteins and DNA-binding proteins.

Pharmacological significance of ZNF19

ZNF19 is expressed in a variety of tumors, including liver cancer, breast cancer, and kidney cancer. Studies have shown that the expression level of ZNF19 is positively correlated with tumor invasion and metastasis. In addition, the expression level of ZNF19 is also related to the survival rate of tumor patients. Therefore, ZNF19 is considered a promising target for tumor therapy.

Drug targets of ZNF19

The pharmacological significance of ZNF19 stems from its potential as a drug target. Currently, a variety of drugs are used to treat ZNF19-related tumors, including inhibitors, imatinib, and nutlin. These drugs inhibit the function of ZNF19 through different mechanisms to achieve the purpose of treating tumors.

Biomarkers for ZNF19

ZNF19 can also serve as a biomarker to detect the development of certain diseases and the effectiveness of treatments. For example, some studies have shown that the expression level of ZNF19 can be used as an important biomarker for the prognosis of kidney cancer patients. In addition, ZNF19 can also serve as a monitoring biomarker for surgical treatment and recovery in certain cancer patients.

Clinical applications of ZNF19

As a new biomarker, ZNF19 has broad application prospects in tumor diagnosis, treatment and prognosis. At present, a variety of studies have explored the role of ZNF19 in tumor diagnosis and treatment, and have achieved certain results.

Biological properties of ZNF19

ZNF19 is a transcription factor expressed in multiple cell types. It plays an important role in cell proliferation, differentiation and tumorigenesis. ZNF19 interacts with a variety of proteins, including transcription factors, co-regulated proteins and DNA-binding proteins.

Pharmacological significance of ZNF19

ZNF19 is expressed in a variety of tumors, including liver cancer, breast cancer, and kidney cancer. Studies have shown that the expression level of ZNF19 is positively correlated with tumor invasion and metastasis. In addition, the expression level of ZNF19 is also related to the survival rate of tumor patients. Therefore, ZNF19 is considered a promising target for tumor therapy.

Drug targets of ZNF19

The pharmacological significance of ZNF19 stems from its potential as a drug target. Currently, a variety of drugs are used to treat ZNF19-related tumors, including inhibitors, imatinib, and nutlin. These drugs inhibit the function of ZNF19 through different mechanisms to achieve the purpose of treating tumors.

Biomarkers for ZNF19

ZNF19 can also serve as a biomarker to detect the development of certain diseases and the effectiveness of treatments

Protein Name: Zinc Finger Protein 19

Functions: May be involved in transcriptional regulation

The "ZNF19 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF19 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322